{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:03:36Z","timestamp":1777896216390,"version":"3.51.4"},"reference-count":11,"publisher":"Journal of the ASEAN Federation of Endocrine Societies (JAFES)","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J ASEAN Fed Endocr Soc"],"abstract":"<jats:p>Background. Prolonged glucocorticoid therapy may result in multi-organ complications and adrenal insufficiency (AI). To mitigate these risks, clinicians typically taper and discontinue treatment once the underlying disease is controlled. Prior to withdrawal, adrenal function is assessed through dynamic testing. However, dynamic testing often requires multiple blood samples for cortisol measurement, continuous patient monitoring for several hours, and close supervision by medical staff throughout the procedure to assess potential adverse effects. In addition, dynamic tests are typically costly and not all healthcare facilities are equipped to perform such procedures.\nObjective. Evaluate the diagnostic performance of baseline cortisol and clinical parameters in the assessment of adrenal insufficiency.\nMethodology. Cross-sectional study of 96 patients on prolonged glucocorticoid treatment at Nguyen Tri Phuong hospital. Insulin tolerance test (IST) was the gold standard for diagnosis of adrenal insufficiency.\nResults. Among 96 patients, 56 (58.3%) had AI. A positive correlation was observed between baseline cortisol levels and peak cortisol levels during the insulin tolerance test, demonstrating a moderately strong association (r = 0.62, p &lt;0.001). Baseline cortisol had good diagnostic performance, with areas under the receiver operating characteristic curve (AUROC) of 0.83 [95% confidence interval (CI): 0.78-0.89]. If the optimal cutoff value for morning serum cortisol is set at 9.0 \u03bcg\/dL, the test demonstrates a sensitivity of 69% and a specificity of 67%. We observed that the morning serum cortisol cutoff of 3 \u03bcg\/dL had a positive predictive value (PPV) of 100% and the morning serum cortisol cutoff of 15 \u03bcg\/dL had a negative predictive value (NPV) of 100%. Among the predictive models for AI, the model incorporating baseline characteristics such as Cushingoid appearance, duration of glucocorticoid therapy, history of hypertension, and baseline cortisol demonstrated the highest predictive accuracy, with an AUC of 0.87 (95% CI: 0.80-0.94).\nConclusion. The assessment of baseline cortisol in conjunction with baseline characteristics offers a reliable method for predicting the risk of adrenal insufficiency, thereby minimizing the necessity for expensive and intricate dynamic testing. In circumstances where dynamic testing is not feasible due to limitations in resources, cost, or expertise, we advocate for the implementation of a model that incorporates baseline characteristics and cortisol levels. This approach provides a practical, cost-effective solution for evaluating adrenal function, requiring only a single blood sample and ensuring broader accessibility.<\/jats:p>","DOI":"10.15605\/jafes.041.01.5195","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:18:03Z","timestamp":1777623483000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Value of Key Clinical Characteristics and Baseline Cortisol in Assessing Adrenal Function in Patients Receiving Glucocorticoid Therapy"],"prefix":"10.15605","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3978-2576","authenticated-orcid":false,"given":"Dung Truc","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuan Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khanh Quang","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6244","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"85240","doi-asserted-by":"crossref","unstructured":"Chabre O, Goichot B, Zenaty D, Bertherat J. Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality. Ann Endocrinol (Paris). 2017;78(6):490-4 https:\/\/pubmed.ncbi.nlm.nih.gov\/29174931 https:\/\/doi.org\/10.1016\/j.ando.2017.10.010","DOI":"10.1016\/j.ando.2017.10.010"},{"key":"85241","doi-asserted-by":"crossref","unstructured":"Charoensri S, Chailurkit L, Muntham D, Bunnag P. Serum dehydroepiandrosterone sulfate in assessing the integrity of the hypothalamic-pituitary-adrenal axis. J Clin Transl Endocrinol. 2017;7:42-6 https:\/\/pubmed.ncbi.nlm.nih.gov\/29067249 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5651301 https:\/\/doi.org\/10.1016\/j.jcte.2017.01.001","DOI":"10.1016\/j.jcte.2017.01.001"},{"key":"85242","doi-asserted-by":"crossref","unstructured":"Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014;383(9935):2152-67 https:\/\/pubmed.ncbi.nlm.nih.gov\/24503135 https:\/\/doi.org\/10.1016\/S0140-6736(13)61684-0","DOI":"10.1016\/S0140-6736(13)61684-0"},{"key":"85243","doi-asserted-by":"crossref","unstructured":"Broersen LHA, Pereira AM, J\u00f8rgensen JOL, Dekkers OM. Adrenal insufficiency in corticosteroids use: Systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(6):2171-80 https:\/\/pubmed.ncbi.nlm.nih.gov\/25844620 https:\/\/doi.org\/10.1210\/jc.2015-1218","DOI":"10.1210\/jc.2015-1218"},{"key":"85244","doi-asserted-by":"crossref","unstructured":"Pelewicz K, Mi\u015bkiewicz P. Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice. Diagnostics (Basel). 2021;11(4):728 https:\/\/pubmed.ncbi.nlm.nih.gov\/33923971 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8072923 https:\/\/doi.org\/10.3390\/diagnostics11040728","DOI":"10.3390\/diagnostics11040728"},{"key":"85245","doi-asserted-by":"crossref","unstructured":"Beuschlein F, Else T, Bancos I, Hahner S, Hamidi O, van Hulsteijn L, et al. European Society of Endocrinology and Endocrine Society joint clinical guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. Eur J Endocrinol. 2024;190(5):G25-G51 https:\/\/pubmed.ncbi.nlm.nih.gov\/38714321 https:\/\/doi.org\/10.1093\/ejendo\/lvae029","DOI":"10.1093\/ejendo\/lvae029"},{"key":"85246","unstructured":"Tran QN, Nguyen TK. Nghi\u00ean c\u1ee9u suy ch\u1ee9c n\u0103ng v\u1ecf th\u01b0\u1ee3ng th\u1eadn \u1edf b\u1ec7nh nh\u00e2n d\u00f9ng glucocorticosteroid d\u00e0i h\u1ea1n b\u1eb1ng c\u00e1c nghi\u1ec7m ph\u00e1p \u0111\u1ed9ng. T\u1ea1p Ch\u00ed Y h\u1ecdc Th\u00e0nh Ph\u1ed1 H\u1ed3 Ch\u00ed Minh. 2014;18(4):60-79"},{"key":"85247","doi-asserted-by":"crossref","unstructured":"Erturk E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab. 1998;83(7):2350-4 https:\/\/pubmed.ncbi.nlm.nih.gov\/9661607 https:\/\/doi.org\/10.1210\/jcem.83.7.4980","DOI":"10.1210\/jcem.83.7.4980"},{"key":"85248","doi-asserted-by":"crossref","unstructured":"H\u00e4gg E, Asplund K, Lithner F. Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency. Clin Endocrinol (Oxf). 1987;26(2):221-6 https:\/\/pubmed.ncbi.nlm.nih.gov\/3311477 https:\/\/doi.org\/10.1111\/j.1365-2265.1987.tb00780.x","DOI":"10.1111\/j.1365-2265.1987.tb00780.x"},{"key":"85249","doi-asserted-by":"crossref","unstructured":"Han AJ, Suresh M, Gruber LM, Algeciras-Schimnich A, Achenbach SJ, Atkinson EJ, et al. Performance of dehydroepiandrosterone sulfate and baseline cortisol in assessing adrenal insufficiency. J Clin Endocrinol Metab. 2025;110(9):e3117-24 https:\/\/pubmed.ncbi.nlm.nih.gov\/39657727 https:\/\/doi.org\/10.1210\/clinem\/dgae855","DOI":"10.1210\/clinem\/dgae855"},{"key":"85250","doi-asserted-by":"crossref","unstructured":"Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 13th ed. Canada: John Wiley and Sons; 2013.","DOI":"10.1002\/9781118548387"}],"container-title":["Journal of the ASEAN Federation of Endocrine Societies"],"original-title":[],"link":[{"URL":"https:\/\/asean-endocrinejournal.org\/index.php\/JAFES\/article\/download\/5195\/5338","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/asean-endocrinejournal.org\/index.php\/JAFES\/article\/download\/5195\/5338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:18:05Z","timestamp":1777623485000},"score":1,"resource":{"primary":{"URL":"https:\/\/asean-endocrinejournal.org\/index.php\/JAFES\/article\/view\/5195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":11,"URL":"https:\/\/doi.org\/10.15605\/jafes.041.01.5195","relation":{},"ISSN":["2308-118X","0857-1074"],"issn-type":[{"value":"2308-118X","type":"electronic"},{"value":"0857-1074","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}